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The dwindling supply of antibiotics that remain effec-
tive against drug-resistant bacterial pathogens has
precipitated efforts to identify new compounds that
inhibit bacterial growth using untapped mechanisms
of action. Here, we report both (1) a high-throughput
screening methodology designed to discover chem-
ical perturbants of the essential, yet unexploited,
process of bacterial iron homeostasis, and (2) our
findings from a small-molecule screen of more than
30,000 diverse small molecules that led to the
identification and characterization of two spiro-indo-
line-thiadiazoles that disrupt iron homeostasis in
bacteria. We show that these compounds are intra-
cellular chelators with the capacity to exist in two
isomeric states. Notably, these spiroheterocyles un-
dergo a transition to an open merocyanine chelating
form with antibacterial activity that is specifically
induced in the presence of its transition-metal target.
INTRODUCTION
The role of iron in sustaining life bears a complexity that is unique
among micronutrients. Although essential for the survival of
virtually all organisms, iron has highly limited bioavailability,
where it is insoluble at neutral pH and is tightly bound by proteins
in vertebrate hosts (Fischbach et al., 2006). As such, biology has
elaborated important systems to acquire iron and, in the case of
bacterial infection, there is an intense competition between the
host and pathogen for this nutrient. Indeed, documentation
exemplifying the struggle between host and pathogen dates
back to the 1940s, where an iron-sequestering agent in human
blood plasma (now known to be transferrin) was found to inhibit
bacterial growth (Schade and Caroline, 1946). Humans maintain
levels of free iron that are on the stringent order of 1018 M in
most tissues—a concentration that is even further reduced
during infection (Bullen et al., 2005). Such a strategy on behalf
of the host to deny essential nutrients to the invading pathogen
is referred to as nutritional immunity (Hood and Skaar, 2012),
where numerous studies support that interfering with this host136 Chemistry & Biology 21, 136–145, January 16, 2014 ª2014 Elsevdefense mechanism by increasing the amounts of available
iron during infection results in increased bacterial virulence for
a number of different pathogens both in the laboratory (Bullen
et al., 1968; Forsberg and Bullen, 1972; Wright et al., 1981)
and during human cohort studies (Murray et al., 1978; Sazawal
et al., 2006).
Because the requirement for iron far exceeds concentrations
that are typically biologically available, bacteria produce high-
affinity chelating agents known as siderophores, where patho-
gens carrying mutations in genes responsible for siderophore
biosynthesis have been found to display attenuated virulence
in animal-infection models (Crouch et al., 2008; Dale et al.,
2004; Meyer et al., 1996). Thus, strategies aimed at interfering
with bacterial iron homeostasis through either the application
of synthetic chelators or by interfering with siderophore-medi-
ated iron acquisition are widely regarded as having high potential
as therapeutic interventions for bacterial infection (Foley and
Simeonov, 2012). Nevertheless, there are currently no antibac-
terial therapies targeting iron homeostasis in bacteria.
The widespread emergence of drug-resistant bacterial infec-
tions is commonly attributed to a lack of innovation in modern
antibacterial drug discovery and a consequent decline in the
development pipeline for new antibiotics. In the work reported
here, we describe an approach to screen for chemical pertur-
bants of bacterial iron assimilation and report on the discovery
of two structurally related antibacterial chemicals that interfere
with iron homeostasis in Escherichia coli. Remarkably, these
compounds are bistable, spiro-indoline-thiadiazoles that are
selectively triggered by transition metals to undergo a switch
from a closed spiro to open merocyanine isomer capable of
intracellular metal chelation.RESULTS
Systems Approach Validates Iron-Sensitive Conditions
Prior to initiating our high-throughput chemical screen we first
established conditions for which small-molecule inhibitors of
iron homeostasis could be detected. The strategy was to
make E. coli susceptible to such perturbants with a sublethal
concentration of the extracellular metal chelator EDTA. Using
an ordered E. coli gene-deletion collection of 4,320 strains
(Baba et al., 2006), we established that an otherwise subinhibi-
tory concentration of EDTA (0.8 mM) could profoundly perturbier Ltd All rights reserved
Table 1. E. coli Strains Carrying Mutations in Genes Involved in
Iron Homeostasis Are Sensitive to the Presence of EDTA
Deletion
Strain
Sensitization
Index Gene Description
entA* 11.02 2,3-dihydro-2,3-dihydroxybenzoate
dehydrogenase
fes* 9.99 enterochelin esterase
entF* 9.07 enterochelin synthetase, component F
aroA* 8.92 3-enolpyruvylshikimate-5-phosphate
synthetase
yfgA 7.66 transmembrane component of
cytoskeleton
aroC* 5.99 chorismate synthase
yraP 5.52 lipoprotein
yibP 4.81 murein hydrolase
aroB* 4.73 3-dehydroquinate synthase
entC* 4.52 isochorismate synthetase
fepG* 4.12 ferric enterobactin ABC transporter—
membrane subunit
ompC 4.06 outer membrane protein
tatA 3.92 membrane translocation of
periplasmic proteins
tolB 3.92 tolerance to colicins E2, E, A, and K
entB* 3.88 2,3-dihydro-2,3-dihydroxybenzoate
synthetase
aroD* 3.81 3-dedydroquinate dehydratase
tonB* 3.55 uptake of chelated Fe and
cyanocobalamin; energy transducer
fepD* 3.54 ferric enterobactin ABC transporter—
membrane subunit
ompR 3.30 activator protein for osmoregulation
of OmpC and OmpF
clpP 3.16 ClpP ATP-dependent protease
proteolytic subunit
pal 3.15 peptidoglycan lipoprotein
gpml 3.12 2,3-bisphosphoglycerate-independent
phosphoglycerate mutase
slyB 3.10 putative lipoprotein
fepB* 3.07 ferric enterobactin ABC transporter—
periplasmic binding protein
wzxE 3.07 lipid III flippase
znuC 3.02 high-affinity ABC transport system
for zinc
znuA 2.93 high-affinity ABC transport system
for zinc
List of all E. coli deletion strains sensitive to EDTA, where those strains
carrying a deletion in genes involved in iron homeostasis are indicated
with an asterisk. Gene descriptions were identified using Ecocyc (Keseler
et al., 2013) and Colibri (Me´digue et al., 1993). See also Figure S1.
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Chelator Perturbs Bacterial Fe2+ Homeostasisthe growth of strains with deletions in genes involved in iron
homeostasis (Figure S1 available online). Indeed, 27 strains
showed significantly reduced growth at this concentration of
EDTA, where 13 of those strains contained deletions in genes
involved in iron assimilation (Table 1) (Keseler et al., 2013;
Me´digue et al., 1993).Chemistry & Biology 21, 136High-Throughput Chemical Screen Identifies
Spiro-Indoline-Thiadiazole Inhibitors of E. coli Iron
Homeostasis
Having demonstrated through our validation screen of EDTA
against the nonessential gene-deletion collection the ability to
detect iron-sensitive targets under such iron-deplete conditions,
we conducted a high-throughput screen of E. coli BW25113
against30,880compounds in thepresenceofEDTAand identified
280 compounds that were growth inhibitory (Figures 1 and S2).
The primary screening data showed good reproducibility along
with high quality Z0-factor statistical scores of 0.81 and 0.82, for
replicates 1 and 2, respectively (Zhang et al., 1999) (Figure S3).
Because we were only interested in selecting compounds that
inhibited bacterial growth in an iron-limited environment (specif-
ically, in the presence of EDTA), we further narrowed this list of
molecules by eliminating compounds that were also growth
inhibitory in the absence of EDTA, yielding 136 compounds.
EDTA has been shown to adversely affect the integrity of the
outer membrane of Gram-negative organisms leading to sensiti-
zation toward toxic compounds otherwise unable to penetrate
the cell (Ejim et al., 2011). To select against compounds that
inhibited the growth of E. coli due to the membrane-compro-
mising, versus the iron-limiting, effects of EDTA, we used a
hyperpermeable E. coli strain (MC1061) (Casadaban and Cohen,
1980; Li et al., 2004) against which to test the active molecules.
Specifically, to identify those compounds that resulted in growth
inhibition due to the membrane-permeabilizing conditions
created by EDTA, we tested the 136 compounds against the
genetically hyperpermeable strain, MC1061, with the rationale
that any compounds producing a growth-inhibitory effect when
grown under metal-replete conditions would not likely be
involved in disrupting iron homeostasis. From this assay, we
determined that the majority of the 136 molecules showed
activity against MC1061 under metal-replete conditions; hence,
we eliminated those compounds from further study and focused
on the remaining 13 molecules, which were not active against
MC1061 in LB media, yet showed activity against BW25113 in
the presence of EDTA in our primary screen. Next, to further
avoid any confounding effects resulting from the use of EDTA,
we conducted assays in minimal media treated with the transi-
tion-metal-chelating resin Chelex 100, where we verified that
six of the remaining 13 compounds were growth-inhibitory to
the wild-type strain under the respective metal-deplete condi-
tions. Lastly, we investigated whether activity from the six com-
pounds could be suppressed by added iron or apo-enterobactin
and found that growth inhibition was reversed in the presence of
each iron source for three compounds (Figure 2).
Among the active compounds identified was the known intra-
cellular iron chelator, 1,10-phenanthroline, providing an internal
positive control for the screen’s sensitivity to detect perturbants
of iron homeostasis; in addition to two spiro-indoline-thiadiazole
analogs, 5-bromo-1-methyl-50-phenyl-30H-spiro[indoline-3,20-
[1,3,4]thiadiazol]-2-one (compound 1a) and 5-ethyl-50-phenyl-3-
0H-spiro[indoline-3,20-[1,3,4]thiadiazol]-2-one (compound 1b).
To confirm that our assay conditions specifically identified com-
pounds involved in perturbing the homeostasis of iron versus
that of another biological metal, we employed the known intra-
cellular zinc chelator, N,N,N0N0-tetrakis-(2-pyridylmethyl)-ethyle-
nediamine (TPEN)—that binds both iron and zinc with log–145, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 137
Figure 1. Strategy to Identify Inhibitors of Bacterial Iron
Homeostasis
See also Figures S2 and S3.
Figure 2. Activity of Compounds Is Suppressed by Each Apo-
Enterobactin, Ferrous Chloride, and Ferric Chloride
(A) Chemical structures of active molecules (1,10-phenanthroline abbreviated
to PHEN).
(B) Growth of E. coli (black bar) in Chelex 100-treated minimal media was
inhibited in the presence of active compounds. Lethal activity of the respective
drugs was suppressed by the addition of 16 mM of each apo-enterobactin
(diagonal lined bar), ferrous chloride (gray bar), and ferric chloride (dotted bar).
Bar graphs represent the mean and ±SD for three samples.
See also Figure S4.
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Chelator Perturbs Bacterial Fe2+ Homeostasisstability constants of 14.61 and 15.58, respectively (Anderegg
et al., 1977)—and found that growth inhibition of E. coli by
TPEN could not be suppressed by the addition of apo-entero-
bactin (data not shown).
Compound 1a Is a Specific Chelator of Divalent
Transition Metals and Is Selective for Fe2+ over Fe3+
To determine whether the spiro-indoline-thiadiazole analogs
acted in a similar fashion to 1,10-phenanthroline through metal
chelation, we conducted growth-suppression assays using
various metals. Although 1,10-phenanthroline primarily exerts
its intracellular effects on the chelation of Fe2+, the chelator is
also capable of binding a range of other transition metals.
Thus, we reasoned that if antibacterial activity of 1a and 1b could
be suppressed by metals other than iron, in particular by transi-
tion metals that are known to form greater relative stabilities
when coordinated with a ligand, such as described by the
Irving-Williams series (Irving and Williams, 1953), then chelation
rather than inhibition of a protein target would be a compelling
hypothesis for compound mode of action. We found that, like
that for 1,10-phenanthroline, addition of a transition metal other
than iron could achieve full suppression of activity of each 1a and
1b; however, supplementation with alkaline earth metals, Ca2+
and Mg2+, resulted in suppression that was 10% or less (Fig-
ure S4). Together, these investigations suggested that the
mode of action of these analogs was due to metal chelation
where the specificity was for transition metals.
An observation during the suppression experiments was that
the addition of certain transition metals to each 1a and 1b
resulted in an immediate bathochromic shift. Although the active
compounds have not been previously reported to display
inducible chromophoric behavior, similar classes of stimuli-trig-
gered chromophoric compounds are the spiropyrans and the
spirooxazines.138 Chemistry & Biology 21, 136–145, January 16, 2014 ª2014 ElsevBased on availability for resupply, we chose 1a as the repre-
sentative analog to explore whethermetal complexation resulted
in compound isomerization and color change. To accomplish
this, we employed visible region spectrophotometry and showed
that where 1a alone absorbs in the 420 nm region, increasing
concentrations of Fe2+ resulted in a dramatic redshift in absorp-
tion with a lmax of 501 nm (Figure 3). The corresponding titration
indicated a stoichiometry of two molecules of 1a with one Fe2+
(Figure 3, inset). Using the Benesi-Hildebrand method (Benesi,
1949) we determined the stability constant between 1a and
Fe2+ to be 1014.3 M2. Interestingly, probing the spectrophoto-
metric behavior of 1a exposed to other metals revealed a redshift
to the 450–550 nm range upon the addition of each Zn2+, Cu2+,
Ni2+, Co2+, and Mn2+ (Figure S5), where we determined the
stability constants between 1a and each metal to be 1013.8
M2, 1013.3 M2, 1013.7 M2, 1013.9 M2, and 1014.5 M2, respec-
tively (Figure S6). However, wewere unable to detect a change in
absorbance of 1a when in the presence of Fe3+, Ca2+, or Mg2+.
X-Ray Crystallography Reveals Binding Nature
of Ligand-Metal Complex
To characterize the means by which 1a chelates transition
metals we conducted X-ray single crystal analysis. Maroon crys-
tals of 1a-Fe2+ and 1a-Zn2+ complexes were obtained by slow
evaporation in a methanol-chloroform (1:1, v/v) solution. Single
crystals were isolated and used for slow diffraction data collec-
tions. Structure analyses gave similar molecular structures for 1a
when complexed to either Fe2+ (Figure 4; Table S1) or Zn2+ier Ltd All rights reserved
Figure 3. Compound 1a Binds Ferrous Iron
Compound 1a undergoes a bathochromic shift in the presence of Fe2+. Visible
absorbance spectroscopy of 20 mM compound 1a (black line) with increasing
concentrations of Fe2+ from 2 mM (light red) to 10 mM (dark red). Concentra-
tions of Fe2+ from 12 mM (dark blue) to 16 mM (light blue) resulted in precipi-
tation of the ligand-Fe2+ complex. Inset: titration of compound 1a at lmax
501 nm with increasing Fe2+ concentrations. To account for the precipitate
formed after the addition of 10 mM Fe2+, the titration curve was generated by
plotting Fe2+ concentration against the differential absorbance (A501 nm –
A420 nm).
See also Figures S5 and S6.
Figure 4. Single Crystal Structure of Compound 1a-Fe2+ Complex
Ellipsoids are at 50% probability and spheres representing hydrogen atoms
are of arbitrary size. The structure of the 1a-Fe2+ complex is deposited in
Cambridge Crystallographic Data Centre, registry number 931217.
See also Table S1 and Figure S7.
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Chelator Perturbs Bacterial Fe2+ Homeostasis(Table S1). In contrast to the closed structure, we observed that
when bound to Fe2+ or Zn2+, 1a displayed an open merocyanine
isomer generated via heterocyclic cleavage through the tetrahe-
dral spirocarbon. 1H and 13C nuclear magnetic resonance (NMR)
spectroscopy of 1a in the absence of metal confirmed an intact
Cspiro—S bond (Figures S7A–S7E), indicating that 1a exists in the
closed isomeric state under conditions where transition metals
are absent. Due to the paramagnetic properties of iron we
used ZnCl2 to show that addition of the transition metal to 1a
resulted in a reduced intensity of the spiro signal and the appear-
ance of an imine signal, consistent with the formation of the 1a
merocyanine isomer (Figures S7F and S7G). Thus, isomerization
of 1a from the closed spiro to open merocyanine form is induced
by the transition metal that it binds to (Figure 5).
To investigate the potential reversibility of 1a between its open
and closed isomers we demonstrated via NMR spectroscopy
analysis that the addition of EDTA (that has a reported log stabil-
ity constant for Zn2+ of 16.5; Liu and Hider, 2002a) to the 1a-Zn2+
complex resulted in removal of the metal from the merocyanine
ligand and isomerization of 1a back to its closed spiro form (Fig-
ures S7H and S7I).
The Merocyanine Isomer of 1a Is Responsible for
Antibacterial Activity
The finding that 1a could exist in one of two distinct chemical
states prompted us to question whether its antibacterial activity
was the result of the closed or open spiro isomer. To address
this, we tested two chemical analogs of 1a: compound 1c, a
spiro-indole-thiadiazole analog that lacks the bromine and
methyl substituents of 1a; and compound 1d, a spiro-indole-
diazole, which differs from 1c by replacement of the metal-coor-
dinating sulfur with a methylene substituent (Figure 6A). WeChemistry & Biology 21, 136hypothesized that if chelation was responsible for the mecha-
nism of action then substituting sulfur with carbon should abolish
compound opening and, in turn, antibacterial activity. Growth
inhibition assays of E. coli grown in Chelex 100-treated minimal
media revealed a minimum inhibitory concentration (MIC) of
32 mM and >128 mM (limited by compound solubility) for 1c
and 1d, respectively. Further, upon addition of Fe2+ to each 1c
and 1d in a 1:2 ratio, absorbance spectroscopy detected a
redshift in absorbance with a lmax at 490 nm for the former deriv-
ative. In contrast, the latter had a featureless visible spectrum
that was unaffected by addition of Fe2+ (Figure 6B). Because
1d lacked a visible spectrum, we sought to confirm our conclu-
sion regarding the inability of 1d to bind Fe2+ by performing a
competition assay between 1d and the known iron-binding
agent, ferrozine, where the latter produces a visible spectrum
with a lmax of 562 nm upon complexation with Fe
2+ (Stookey,
1970). We showed that preincubation of Fe2+ with 1d followed
by treatment with ferrozine resulted in formation of the Fe2+-
ferrozine complex, indicating that 1d was unable to compete
with ferrozine for Fe2+, further demonstrating that 1d is incapable
of chelating Fe2+ (Figure 6C). Together, these results support a
model where the sulfur residue of 1c is required for compound
activity such that, in the presence of transition metals, the spiro-
heterocycle undergoes isomerization to the open metal-bound
form, where chelation is the mechanism of antibacterial action
of 1a.
Antibacterial Activity of 1a Occurs Intracellularly
To ascertain whether chelation and, in turn, growth inhibition by
compound 1a occurs extra- or intracellularly we used combina-
tions of known chelators and investigated signature interactions
between these molecules. Chemical-chemical interaction pro-
files using known bioactive compounds have been identified
as a powerful means to probe mechanism of novel compounds
(Farha and Brown, 2010; Yeh et al., 2006). Therefore, using the
known extracellular chelators, EDTA and pentetic acid (DTPA);–145, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 139
Figure 5. Proposed Mechanism of Fe2+-
Induced Isomerization of Compound 1a to
the Open Merocyanine Form
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Chelator Perturbs Bacterial Fe2+ Homeostasisthe intracellular iron chelator, 1,10-phenanthroline; and the intra-
cellular zinc chelator, TPEN, we generated interaction profiles
that we then compared to those between 1a and the known
chelators. We observed synergy between EDTA and each
1,10-phenanthroline, TPEN, and 1a and detected slight antago-
nism between the two extracellular chelators, EDTA and DTPA
(Figure 7A) (Pillai et al., 2005). Interaction profiles between
each of the two known intracellular chelators and 1a showed
slight synergy, where 1a in combination with DTPA produced a
synergistic interaction. Combining 1,10-phenanthroline and
TPEN resulted in synergy.We hypothesized that if 1awere acting
as an extracellular chelator then we would have expected to see
a similar antagonistic interaction signature with each EDTA and
DTPA as was produced upon combination of the two respective
extracellular chelators; however, we instead observed synergy
between 1a and each EDTA and DTPA—where synergy was
also observed between EDTA and each 1,10-phenanthroline
and TPEN—suggesting 1a to behave more similarly to the intra-
versus extracellular chelators. Indeed, these conclusions are
consistent with the screening conditions under which these
chelators were discovered. With a concentration of 0.8 mM
EDTA in the media, growth inhibition upon addition of 10 mM
compound 1a would be difficult to explain were the molecule
simply another extracellular chelator.
To further confirm our hypothesis that 1a functions
intracellularly, we performed a time course assay where the
supernatant of 1a-treated E. coli was monitored via visible
spectroscopy (Figure 7B). We show that upon immediate treat-
ment of cells with 1a the amount of compound (based on the
absorbance spectrum of 1a between 600 and 350 nm) in the
supernatant was identical to the absorbance spectrum of 1a
from that of the cell-free sample. At 1 hr posttreatment, the
amount of 1a from the cell-containing supernatant was
approximately half that of the spectrum observed from the
cell-free sample, and at 2 hr posttreatment, the absorbance
of 1a-treated cells was identical to that of the spectrum shown
for the untreated-cell sample, indicating that 1a was no longer
detectable in the supernatant.
DISCUSSION
Among the greatest hurdles for lead identification in antibiotic
drug discovery is the identification of compound mechanism of
action. Yet, at a time when the scarcity of effective antibiotics
is hindering the treatment of multidrug resistant bacterial infec-
tions, it is incumbent upon researchers to identify novel antibac-
terials and to accelerate the means by which mechanism is
deciphered. Here, we describe a mechanism-guided screen
for inhibitors of bacterial iron homeostasis and the discovery
of two spiro-indoline-thiadiazole intracellular chelators with anti-
bacterial activity.140 Chemistry & Biology 21, 136–145, January 16, 2014 ª2014 ElsevIron is an essential micronutrient whose availability is well
documented to be inextricably linked to successful pathogen-
mediated host infection; however, antibacterial agents that
target bacterial iron homeostasis are absent from the clinic.
Studies using the fungal pathogen, Aspergillus fumigatus (Pinto
and Moore, 2009), and the yeast, Saccharomyces cerevisiae
(Simm et al., 2011), have previously demonstrated the capability
of high-throughput screens to detect small molecules that inhibit
iron and zinc homeostasis in each of these respective organ-
isms; however, such investigations have not be reported for
bacteria. In this study, we have both validated a screening
methodology that specifically selects for compounds that inhibit
bacterial iron homeostasis and report on a series of small
molecules that are toxic to E. coli via metal-mediated isomeriza-
tion and iron chelation.
Iron can exist in a range of oxidation states, although it is pri-
marily found in either the Fe3+ ferric form under aerobic condi-
tions, or in the reduced Fe2+ ferrous state in environments where
oxygen is absent (Andrews et al., 2003). Siderophores, such as
enterobactin found in E. coli, are highly specific for Fe3+. Under
iron-limiting conditions, E. coli synthesizes and excretes entero-
bactin into the extracellular milieu where the siderophore
scavenges iron and forms a tight association with Fe3+. The
resulting ferri-siderophore complex is subsequently imported
into the bacterial cell where Fe3+ is reduced to Fe2+ and in turn
released from enterobactin (Andrews et al., 2003). In our valida-
tion screen employing the nonessential gene-deletion library in
E. coli, we observed that strains most sensitive to iron depletion
were those mutants incapable of siderophore biosynthesis or
uptake—stated otherwise, these are strains unable to accom-
plish Fe3+ acquisition. Although the chemical library screened
in this study did not yield compounds targeting enterobactin
biosynthesis or import, those deletion strains sensitive to the
presence of EDTA comprise a potential target list for future
high-throughput screens conducted under parameters identical
to those reported here. In particular, barring chelation as the
mechanism of action, likely potential targets of any compounds
identified from such screening conditions are those enzymes
and proteins absent from the deletion strains reported here to
be sensitive to an iron-limited environment.
Although Fe3+ is the predominant iron species found in aerobic
environments, within the bacterial cell iron has been shown to
exist primarily in the reduced Fe2+ state (Keyer and Imlay,
1996). Thus, when bacteria are grown in an oxygen-rich environ-
ment, although it is the ferric form that enters the cell, iron is
rapidly converted to and maintained in the ferrous state. We
therefore hypothesized that, in addition to having the potential
to detect compounds that inhibit Fe3+ acquisition, our screening
conditions would be amenable to the identification of com-
pounds that perturb the intracellular Fe2+ iron pool. Thus, in
our final assay following the high-throughput screen, in orderier Ltd All rights reserved
Figure 6. TheMerocyanine Form of 1a Is Responsible for Antibacte-
rial Activity
(A) Chemical structure of compounds 1c and 1d.
(B) Vertical stacking of the visible spectra of 20 mM compound 1c with 10 mM
Fe2+ (i); 20 mM compound 1c alone (ii); 20 mM compound 1d with 10 mM Fe2+
(iii); 20 mMcompound 1d alone (iv). Hashed line indicates lmax of compound 1c
with Fe2+ at 490 nm. Samples were assayed in Chelex 100-treated HEPES
(10 mM, pH 7.4).
(C) Compound 1d (40 mM, hashed black line) was incubated for 10 min at room
temperature with ferrous iron solution (30 mM, solid gray line) (10 mM FeSO4
stock in 0.5N HCl) in buffer (8 mM hydroxyl amine, 75 mM ammonium acetate,
pH 9.5). Following incubation of 1d and FeSO4, ferrozine (40 mM) was then
added to the reaction mixture, where spectra monitoring formation of the iron-
ferrozine complex (solid black line) were collected between 600 and 400 nm (i).
In a control experiment to show that preincubation of iron with a bona fide iron
chelator prevents subsequent formation of the iron-ferrozine complex (solid
black line), EDTA (40 mM, hashed black line) was preincubatedwith ferrous iron
solution (30 mM, solid gray line) for 10min at room temperature. In contrast to (i)
the addition of ferrozine (40 mM) to EDTA resulted in a featureless visible
spectrum (ii).
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Chelator Perturbs Bacterial Fe2+ Homeostasisto confirm that the molecules of interest were specifically
involved in disrupting iron homeostasis—either by inhibiting
Fe3+ acquisition or through perturbation of intracellular Fe2+
homeostasis—we asked whether compound activity could be
suppressed by supplementing with each apo-enterobactin,
ferrous iron, and ferric iron. Our rationale for using apo-entero-
bactin as a secondary assay was to select for compounds that
specifically perturb iron homeostasis. Namely, we sought to pre-
clude (1) compounds capable of metal chelation that disrupted
the homeostasis of an essential transition metal other than
iron, such as Mn2+ or Zn2+, and (2) compounds that might be in-
activated by iron in our counter screen through the formation of a
chelate complex. Chelex-treated minimal media is iron deplete;
however, as iron is absolutely required for bacterial growth, a
limited amount of iron sufficient to permit growth of E. coli none-
theless remained in the media. Thus, we sought to answer
whether the addition of apo-enterobactin, which would scav-
enge trace iron in the Chelex-treated media and be imported
into the cell as the holo-siderophore, would be sufficient to sup-Chemistry & Biology 21, 136press an inhibitor-induced lethal phenotype. The concentration
of intracellular iron is stringently regulated; therefore, only under
circumstances where intracellular iron was being depleted
would holo-enterobactin be imported into the cell. Therefore, if
growth inhibition by 1a resulted from homeostatic disruption of
ametal other than iron then wewould not expect to see suppres-
sion by enterobactin as the holo-siderophore would not be
imported into the cell if the availability of iron was not disturbed.
Indeed, we showed that growth inhibition by TPEN—whose
principal mechanism of inhibition is through perturbation of
zinc homeostasis, but which also binds other transition metals,
including iron—was not suppressed with supplementation of
apo-enterobactin. Thus, the use of apo-enterobactin as a
counter screen permitted assurance that compound activity of
our molecules of interest was indeed the result of perturbing
either iron acquisition or homeostasis.
Our identification of the known intracellular Fe2+ chelator,
1,10-phenanthroline, served as initial confirmation that the em-
ployed screening conditions were indeed capable of identifying
chemical matter that disrupts Fe2+ homeostasis. Although we
found the activity of 1a and 1bwas suppressed by a series of bio-
logical transition metals—that therefore suggested these spiro-
indoline-thiadiazole analogs to function as chelators—it was still
unclear whether the mechanism of action was through chelation
of Fe2+ or Fe3+. However, by conducting visible region spectro-
photometry and X-ray crystallography analyses, we were able
to show unequivocally that 1a binds Fe2+ in addition to other diva-
lent transition metals. We were unable to identify complex forma-
tion between 1a and the nontransition divalent metals, Ca2+ or
Mg2+; and, more interestingly, we did not detect binding between
1a and Fe3+.Where even the knownchelator 1,10-phenanthroline
is considered to be highly selective for ferrous iron with log stabil-
ity constants for Fe2+ and Fe3+ of 21.0 and 14.1, respectively (Liu
and Hider, 2002b), we report here an unusual example of a syn-
thetic chelator that, although capable of binding Fe2+, appears
to be unable to chelate the oxidized form of iron.
The stability constants of 1a with transition metals implied
the following binding order: Cu2+ < Ni2+ < Zn2+ < Co2+ < Fe2+ <
Mn2+. Although these findings suggest Mn2+ to be the preferred
substrate for 1a in a mixed-metal in vitro environment, a key
consideration when contemplating target metal under biological
conditions is differential metal bioavailability. Specifically, E. coli
has been found to accumulate 10–100 timesmore iron thanman-
ganese (Outten and O’Halloran, 2001), suggesting that the
greater cellular concentration of the former metal may predis-
pose it over manganese to chelation by 1a. Furthermore, the
EDTA-LB conditions under which 1a was initially identified
were identical to those employed to screen the nonessential
gene-deletion collection, where although we detected many
strains carrying mutations in genes involved in iron homeostasis,
we did not identify any such mutants with deletions in genes
responsible for maintaining manganese homeostasis. Hence,
although we found 1a to have a slightly higher stability constant
for Mn2+ over Fe2+, in light of the argument regarding cellular
metal bioavailability as well as our findings from the nonessential
gene-deletion screen—that served as a proxy for the target path-
ways that we could expect to inhibit during a small-molecule
screen—we argue that 1a is indeed perturbing the homeostasis
of Fe2+ over other biological metals.–145, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 141
AB
Figure 7. Compound 1a Functions as an Intracellular versus an Extracellular Chelator
(A) Checkerboard growth assays of the effect of chemical combinations on the growth of E. coli. Dark blue squares to white squares represent full growth and
complete growth inhibition, respectively. The plots are described succinctly by FIC indexes (Pillai et al., 2005), where values of <0.5, 1, and >2.0 indicate
synergistic, additive, or antagonistic compound interactions, respectively. EDTA combined with each 1,10-phenanthroline, TPEN, and 1a resulted in synergy,
with FIC indexes of 0.188, 0.313, and%0.156, respectively. EDTA combined with DTPA produced a slightly antagonistic effect, with an FIC index of 1.125. 1a
combined with each 1,10-phenanthroline and TPEN produced slightly synergistic interactions, with FIC indexes of 0.75 in both cases. 1a and DTPA resulted in a
synergistic interaction with an FIC index of 0.5, and the combination of 1,10-phenanthroline and TPEN yielded synergy, resulting in an FIC index of 0.5.
(B) Samples (1.5 ml) of saturated E. coli cultures in Chelex 100-treated M9minimal media were prepared separately for 0, 1, and 2 hr time points according to the
following: bacteria treated with 40 mM 1a (black solid line); bacteria treated with DMSO solvent (hashed gray line); media alone with 40 mM 1a (gray dotted line);
and media alone with DMSO solvent (gray solid line). Samples (1 hr and 2 hr) were shaken at 250 rpm at 37C, where supernatant from 0 hr samples were
measured immediately. Supernatants were obtained by centrifugation of samples for 6 min at 15,000 rpm, after which the absorbance of each sample was
measured between 600 and 350 nm using quartz cuvettes and a Varian Cary Bio 300 UV-Vis spectrophotometer.
Chemistry & Biology
Chelator Perturbs Bacterial Fe2+ HomeostasisPertaining to the metal-binding chemistry and antibacterial
activity of these spirocompound analogs, of particular interest
to us was the observation that 1a is able to exist in two isomeric
states. There is an extensive literature regarding the spiropyrans
and spirooxazines which, similar to 1a, are bistable compounds
susceptible to isomerization to the merocyanine form when
faced with a specific environmental cue; however, in the
absence of a trigger will spontaneously revert back to the more
stable, closed spiro state (Tian et al., 2010). Indeed, when zinc-
exposed 1a was treated with EDTA we observed reversion of
1a from the merocyanine to the closed state, suggesting the
spiro form of 1a to also be the more stable isomer. In experi-
ments with the chemical analogs, 1c and 1d, we were able to
show that antibacterial activity of 1a and 1b is contingent on
the presence of a sulfur moiety within the diazole, thus inferring
that it is the open merocyanine, rather than the stable spiro iso-
mer that is responsible for antibacterial activity. We report here142 Chemistry & Biology 21, 136–145, January 16, 2014 ª2014 Elsevthe identification of a bistable compound series that is specif-
ically induced by its transition-metal target to assume an active,
antibacterial form.
Our demonstration that the antibacterial activity of 1a results
from the ability of the compound to chelate Fe2+ is, alone,
strongly suggestive of 1a functioning as an intra- versus extra-
cellular chelator. In order for 1a to be active in the extracellular
environment we would expect the compound to be capable of
binding the form of iron that predominates in the aerobic sur-
roundings outside of the cell—which is Fe3+. However, as we
have shown 1a to be incapable of complexing with Fe3+, the
most parsimonious conclusion is that 1a exercises its antibac-
terial activity by chelating the Fe2+ intracellular iron pool. As
evidence tomore conclusively prove this hypothesis, we showed
that chemical-chemical interaction profiles generating signature
relationships between 1a and known intra- and extracellular che-
lators were similar to those interaction profiles observed for otherier Ltd All rights reserved
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Chelator Perturbs Bacterial Fe2+ Homeostasisknown intracellular chelators, yet were quite disparate from
those profiles revealed by known extracellular chelators.
Although we found 1,10-phenanthroline and TPEN to be syner-
gistic upon combination with one another, where 1a with each
of the intracellular chelators was only very mildly synergistic,
we surmise that such observations result from 1a being satu-
rated by the extracellular metal in the LBmedia, in turn rendering
1a unable to adequately chelate iron within the cell. Conversely,
EDTA and DTPA sequestered much of the extracellular metal,
thereby permitting 1a to remain functional intracellularly. Further,
to more convincingly show that 1a is an intracellular chelator, we
demonstrated that the presence of 1a in the supernatant of
1a-treated cells had completely disappeared over the course
of 2 hr, suggesting that 1a migrated from the outside into the
intracellular space.
SIGNIFICANCE
Screeningmethodologies that select for antibacterial matter
with novel modes of action and that concomitantly inform on
compound mechanism can efficiently provide new leads for
new treatment options to address the dearth of effective
antibiotics. In this report, we have provided a means by
which to identify compounds that inhibit bacterial iron
homeostasis—an essential process that is currently under-
exploited as a target and therapeutic avenue by which to
treat bacterial infections. Employing this methodology
to screen 30,000 small molecules, we have identified a
chemical series that acts as an intracellular chelator of
ferrous iron. These compounds are unusual spiro-indoline-
thiadiazoles that are bistable molecules with a capacity to
exist in two unique isomeric states. Remarkably, these com-
pounds undergo a transition from a stable closed spiro
isomer to an open chelating form with antibacterial activity
that is specifically induced in the presence of its transition-
metal target.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Growth Media, and Reagents
E. coli K-12 strain BW25113 was employed for all experiments unless stated
otherwise. The nonessential gene-deletion collection was a kind gift from
Hirotada Mori, where the genetic background of all deletion strains in this
library is E. coli BW25113. All growth experiments were conducted in liquid
media under aerobic conditions. Luria Bertani (LB) medium contained 10 g
of Bacto Tryptone (BD Biosciences), 10 g of sodium chloride, and 5 g of
yeast extract (BD Biosciences) per liter of distilled water. All experiments,
including those involving EDTA, were conducted in LB media, unless stated
otherwise. Minimal media was comprised of 13 M9 minimal salts prepared
from 53 M9 minimal salts stock (Sigma-Aldrich), 0.2% v/v Casamino acids
(BD Biosciences), 10 mM of each aromatic amino acid, L-tyrosine, L-trypto-
phan, and L-phenylalanine, 1 mM thiamine, and 0.4% v/v glucose. Transition
metal-depleted media was generated by passing M9 minimal media over a
column containing Chelex 100 resin (Bio-Rad). The high-throughput
small-molecule screen was conducted using the Canadian Compound
Collection (CCC), which was assembled and is maintained by McMaster
University’s High-throughput Screening Facility. The CCC is comprised of
30,880 small molecules, which are sourced from various vendors, including
ChemBridge, Maybridge, MicroSource Discovery Systems, Prestwick
Chemicals, and Biomol-Enzo Life Sciences. Unless stated otherwise, all
chemicals and reagents, including the metal chelators 1,10-phenanthroline,
EDTA, and TPEN, and metal salts ferrous chloride, ferric chloride,Chemistry & Biology 21, 136zinc chloride, manganese chloride, cobalt chloride, nickel chloride, and
cupric chloride were purchased from Sigma-Aldrich. Resupply of com-
pound 1a and compound 1b were from ChemBridge. Compounds 1c
and 1d were purchased from ChemBridge and Vitas-M Laboratory,
respectively.
LB-EDTA High-Throughput Small-Molecule Screen
E. coli BW25113 was grown overnight at 37C with shaking at 250 rpm in
5 ml LB media to a saturated culture. Bacteria were diluted 1:100 into fresh
LB media, grown to an OD600 nm of 0.3 and diluted again 1:1,000 in LB media
containing 0.8 mM EDTA. A Beckman Biomek FX (Beckman Coulter) was
used for all subsequent liquid handling experiments. EDTA-diluted cells
were transferred at a volume of 198 ml to 96-well plates (Costar) followed
by the addition of 2 ml of each compound dissolved in DMSO (Caledon
Laboratory Chemicals) to achieve a final screening concentration of
10 mM. Alternating positive and negative controls replaced CCC compounds
in both the first and last column of each plate, where controls consisted of
ampicillin (64 mg ml1) and DMSO, respectively. Plates were read at
OD600 nm before and after incubation for 16 hr at 37
C, where the initial
read was later subtracted from the final read in order to account for com-
pounds that contributed to absorbance at 600 nm. Each compound was
screened in duplicate. Bacterial growth was measured via the following
equation:
%growth=

OD600  mOD600low
mOD600high  mOD600low

x100; (Equation 1)
where mOD600low and mOD600high represent the average sterility and bacterial
growth controls, respectively.
Growth Curves and Minimum Inhibitory Concentration
Determinations
All bacterial strains were grown overnight at 37C with shaking at 250 rpm in
5 ml of media, which consisted of either LB or M9 minimal media (where the
latter was the overnight media used for compounds tested in either M9 or
Chelex 100-treated M9 media). Saturated cultures were subsequently diluted
1:100 into either LB or M9minimal media accordingly (where the latter was the
subculture media used for compounds tested in either M9 or Chelex 100-
treated M9 media) and grown to an OD600 nm of 0.3 or 0.2 for growth in LB
and M9 minimal media, respectively. Bacteria were again diluted 1:100,000
into media containing the final concentration of compound to be tested, where
LB or M9 media was used for experiments conducted under transition
metal-replete conditions, and Chelex 100-treated M9 media was employed
formetal-deplete experiments. Bacteria with compoundwere incubated under
stationary conditions at 37C where growth at OD600 nm was measured after
18 hr unless stated otherwise.
EDTA Screen against E. coli Nonessential Gene Deletion Library
Strains from the nonessential gene deletion library arrayed in 96-well plates
were inoculated from frozen stocks into fresh LB media containing 50 mg
ml1 kanamycin using the Duetz cryoreplicator (Duetz et al., 2000). Inoculated
plates were shaken for 18 hr at 37C and 250 rpm to achieve saturated
cultures. Strains were then subcultured at a 1:100 dilution by transferring
2 ml of culture into 198 ml LB containing 50 mg ml1 kanamycin and returned
to shake at 37C and 250 rpm until bacteria reached anOD600 nm of 0.3. Strains
were diluted 1:200where samples were either treated with 0.8mMEDTA or left
to grow in LB media alone. Bacteria were incubated at 37C for 16 hr and
growth was measured and recorded at OD600 nm. Each condition was
performed in duplicate.
Metal- and Apo-Enterobactin-Suppression Experiments
E. coli BW25113 was treated as described above for MIC experiments;
however, rather than testing the final 1:100,000 dilution of bacteria against a
range of compound concentrations, here we added the bacteria to the previ-
ously-established MIC of our compound of interest combined with an equi-
molar concentration of apo-enterobactin or the test metal of interest. Samples
were then incubated under stationary conditions at 37C and bacterial growth
was measured at OD600 nm after 18 hr. Results are represented as the mean
and ± SD for three samples.–145, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 143
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Maroon crystals of the 1a-Fe2+ and 1a-Zn2+ complexes were each generated
by slow evaporation at ambient temperature of a 1:1 (v/v) methanol:chloroform
solution containing 1:1.2 (molar ratio) of 1a powder and either ferrous chloride
or zinc chloride. Crystals of each 1a-Fe2+ and 1a-Zn2+ were observed after
3 weeks and single-crystal X-ray crystallographic analyses were conducted.
Diffraction data were obtained using u-scans via a Bruker SMART6000 CCD
area detector mounted on a fixed-c 3-circle D8 goniometer using a Rigaku
Cu rotating anode with cross-coupled mirrors and CuKa radiation (l =
1.54178 A˚). Data collection, processing, and refinement were accomplished
using APEX2 (Bruker-AXS), SHELXS (Sheldrick, solution), and SHELXL
(Sheldrick, refinement), respectively. Details of data collection and refinement
for 1a-Fe2+ and 1a-Zn2+ are presented in Table S1 and are deposited with the
Cambridge Crystallographic Data Centre, registry number 931217 and
931218, respectively.
Spectroscopic Measurements
Studies were conducted using quartz cuvettes and a Varian Cary Bio 300 UV-
Vis spectrophotometer. Samples were prepared in Chelex 100-treated HEPES
(10mM) at pH 7.4 and assayed according to conditions as stated in the results.
Each experiment was conducted in triplicate and averaged for accuracy. To
maintain iron in a reduced oxidative state experiments involving Fe2+ were
performed under an N2 atmosphere.
Ferrozine Competition Assay
All solutions were prepared as described previously (Viollier et al., 2000).
Briefly, ferrozine (102 M) was prepared in ammonium acetate solution
(102 M). The reducing agent, hydroxylamine hydrochloride (1.4 M) was pre-
pared in analytical grade hydrochloric acid (2 M). Ammonium acetate buffer
(10 M) was prepared at pH 9.5. Experiments were performed as described
in Figure 6C.
Chemical-Chemical Interaction Experiments
For each chemical combination an 8 3 8 matrix was prepared at the appro-
priate drug concentrations. An E. coli BW25113 subculture grown in LB media
to an OD600 nm of 0.3 and was added to the compound assay plate at a final
dilution of 1:200,000. Growth was measured after 18 hr at 37C. Each com-
pound combination was assayed in duplicate where averaged values were
used to calculate the fractional inhibitory concentration (FIC) index.
Time Course Assay Monitoring Intracellular Uptake of 1a by E. coli
A single colony of E. coli BW25113 was grown in 5 ml of M9 minimal media for
18 hr. The saturated culture was then pelleted via centrifugation for 6 min at
15,000 rpm, washed three times with Chelex 100-treated M9 minimal media,
and resuspended in 10 ml of Chelex-treated M9 minimal media. Aliquots
(1.5 ml) of culture were added to separate acid-washed flasks and samples
were prepared as described for Figure 7B.
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